Cargando…
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19
[Image: see text] The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has prompted researchers to pivot their efforts to finding antiviral compounds and vaccines. In this study, we focused on the human host cell transmembrane protease serine 2 (TMPRSS2), which plays an importan...
Autores principales: | Hu, Xin, Shrimp, Jonathan H., Guo, Hui, Xu, Miao, Chen, Catherine Z., Zhu, Wei, Zakharov, Alexey V., Jain, Sankalp, Shinn, Paul, Simeonov, Anton, Hall, Matthew D., Shen, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043206/ https://www.ncbi.nlm.nih.gov/pubmed/34136758 http://dx.doi.org/10.1021/acsptsci.0c00221 |
Ejemplares similares
-
Discovery of TMPRSS2 inhibitors from virtual screening
por: Hu, Xin, et al.
Publicado: (2021) -
An Enzymatic TMPRSS2 Assay for Assessment of Clinical
Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
por: Shrimp, Jonathan H., et al.
Publicado: (2020) -
A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
por: Shrimp, Jonathan H., et al.
Publicado: (2022) -
Hybrid In Silico Approach Reveals
Novel Inhibitors of Multiple SARS-CoV-2 Variants
por: Jain, Sankalp, et al.
Publicado: (2021) -
TMPRSS2 Inhibitor
Discovery Facilitated through an In Silico and Biochemical
Screening Platform
por: Peiffer, Amanda L., et al.
Publicado: (2023)